CRISPR Therapeutics AG (NASDAQ:CRSP)

116.35
Delayed Data
As of Sep 24
 -4.90 / -4.04%
Today’s Change
79.31
Today|||52-Week Range
220.20
-24.01%
Year-to-Date
September Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
Sep 25 / MotleyFool.com - Paid Partner Content
Why CRISPR Therapeutics AG (CRSP) is a Top Stock for the Long-Term
Sep 17 / Zacks.com - Paid Partner Content
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
Sep 23 / MotleyFool.com - Paid Partner Content
3 Explosive Biotech Stocks That Could 10X in 10 Years
Sep 16 / MotleyFool.com - Paid Partner Content
CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know
Sep 22 / Zacks.com - Paid Partner Content
5 Reasons to Buy Vertex Pharmaceuticals (VRTX) Stock Now
Sep 15 / Zacks.com - Paid Partner Content
5 Stocks to Buy in the September Sell-Off
Sep 22 / MotleyFool.com - Paid Partner Content
3 Crash-Ready Stocks to Buy in September
Sep 14 / MotleyFool.com - Paid Partner Content
Is Now the Time to Ditch Pharma Stocks?
Sep 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close121.25
Today’s open119.62
Day’s range116.00 - 120.24
Volume56,839
Average volume (3 months)1,174,375
Market cap$8.9B
Data as of 5:07pm ET, 09/24/2021

Growth & Valuation

Earnings growth (last year)-530.35%
Earnings growth (this year)+181.07%
Earnings growth (next 5 years)-2.37%
Revenue growth (last year)-99.75%
P/E ratio22.5
Price/Sales14,043.90
Price/Book5.18

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.03-0.03%
XLRNAcceleron Pharma Inc+7.81+4.89%
ARWRArrowhead Pharmaceut...+0.69+1.07%
NTLAIntellia Therapeutic...-6.14-3.95%
Data as of 4:14pm ET, 09/24/2021

Financials

Next reporting dateNovember 10, 2021
EPS forecast (this quarter)-$1.74
Annual revenue (last year)$719.0K
Annual profit (last year)-$348.9M
Net profit margin-48,520.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Zug, Zug

Forecasts